Drug:
Reaction: OVERDOSE
20250101 - 20251231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 25703666 |
CA |
||
Acne, Overdose, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, PREDNISONE, |
||||
| 702 | 25703750 |
CA |
||
Condition aggravated, Drug level decreased, Rhinorrhoea, COVID-19, Cytomegalovirus infection, Nasopharyngitis, Off label use, Therapeutic response shortened, Overdose, Underdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 703 | 25703751 |
CA |
||
Cataract, Dry eye, Eye laser surgery, Eye swelling, Nail discolouration, Otorrhoea, Phlyctenular keratoconjunctivitis, Retinal detachment, Vitamin B12 increased, Blood disorder, Ear infection, Eye infection, Rash, Inappropriate schedule of product administration, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, |
||||
| 704 | 25703764 |
CA |
||
Condition aggravated, Vomiting, Gastroenteritis, Psoriasis, Diarrhoea, Arthralgia, Nausea, Drug ineffective, Inappropriate schedule of product administration, Off label use, Underdose, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, BISOPROLOL FUMARATE, CHOLESTYRAMINE, FOLIC ACID, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, METHOTREXATE, METHOTREXATE SODIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, ROSUVASTATIN CALCIUM, TEMAZEPAM, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, RIVAROXABAN, |
||||
| 705 | 25703811 |
CA |
||
Aphthous ulcer, Asthenia, Chest discomfort, Condition aggravated, Dry throat, Pain in extremity, Weight decreased, Weight increased, Arthralgia, Cough, Fatigue, Nasopharyngitis, Nausea, Inappropriate schedule of product administration, Intentional product use issue, Off label use, Overdose, Underdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 706 | 25703814 |
CA |
||
Abdominal discomfort, Anal fissure, Condition aggravated, Fistula, Flatulence, Weight decreased, Blood pressure increased, Malaise, Arthralgia, Headache, Pain, Off label use, Inappropriate schedule of product administration, Intentional product use issue, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MESALAMINE, PREDNISONE, |
||||
| 707 | 25703819 |
CA |
||
Glycosylated haemoglobin increased, Rheumatoid arthritis, Hepatic enzyme increased, Herpes zoster, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, RAMIPRIL, SULFASALAZINE, LEVOTHYROXINE SODIUM, |
||||
| 708 | 25703844 |
CA |
||
Condition aggravated, Maternal exposure during pregnancy, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 709 | 25703939 |
EU |
||
Fall, Febrile neutropenia, Thrombocytopenia, Anaemia, Vomiting, Overdose, Product use issue, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, PREDNISONE, PREDNISONE, ACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PHENOBARBITAL, AMLODIPINE BESYLATE, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, FILGRASTIM, |
||||
| 710 | 25703946 |
CA |
||
Glaucoma, Body temperature increased, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 711 | 25703984 |
CA |
||
Condition aggravated, Headache, Localised infection, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, |
||||
| 712 | 25704099 |
CA |
||
Abdominal distension, Anxiety, Asthenia, Back injury, Blood pressure systolic increased, Condition aggravated, Cough, Crohn^s disease, Dysmenorrhoea, Erythema, Malaise, Nasal congestion, Oropharyngeal pain, Panic attack, Rhinalgia, Sitting disability, Throat irritation, Weight increased, Wheezing, Arthralgia, Dry skin, Eczema, Fatigue, Headache, Insomnia, Nasopharyngitis, Pruritus, Pyrexia, Rash, Rhinitis, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, |
||||
| 713 | 25704197 |
CA |
||
Anal fissure, Anal abscess, Inappropriate schedule of product administration, Incorrect dose administered, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, |
||||
| 714 | 25704255 |
CA |
||
Aphthous ulcer, Condition aggravated, Arthralgia, COVID-19, Lower respiratory tract infection, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, |
||||
| 715 | 25704388 |
CA |
||
Fall, Arthralgia, Pneumonia, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, |
||||
| 716 | 25704477 |
CA |
||
Condition aggravated, Drug ineffective, Drug level decreased, Muscular weakness, Musculoskeletal chest pain, Nasal congestion, Nasal dryness, Tooth disorder, Malaise, Rhinorrhoea, Productive cough, Weight decreased, Cough, Dyspnoea, Fatigue, Sinusitis, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SEMAGLUTIDE, |
||||
| 717 | 25704507 |
GB |
59 | 1 |
Thrombocytopenia, Leukocytosis, Mucosal inflammation, Leukopenia, Neutropenia, Rhinalgia, Neuropathy peripheral, Nausea, Dyspepsia, Diarrhoea, Cellulitis, Alopecia, Platelet count decreased, Fatigue, Delusion of grandeur, Incorrect dose administered, Lymphocyte count abnormal, SARS-CoV-2 test positive, Neutrophil count decreased, Hallucination, auditory, Extrapyramidal disorder, Affective disorder, Psychotic disorder, Schizophrenia, Disease progression, Neutrophil count increased, Seizure, Overdose, COVID-19, Neoplasm progression, Intentional product misuse, Lymphocyte count decreased, Off label use, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, PACLITAXEL, PACLITAXEL, PACLITAXEL, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, CHLORPROMAZINE, CHLORPROMAZINE, CHLORPROMAZINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, LORAZEPAM, LORAZEPAM, LORAZEPAM, PERTUZUMAB, PERTUZUMAB, PERTUZUMAB, PERTUZUMAB, PERTUZUMAB, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, DENOSUMAB, CHLORPHENIRAMINE MALEATE, DENOSUMAB, DENOSUMAB, DULOXETINE HYDROCHLORIDE, DULOXETINE, GENTAMICIN, GENTAMICIN SULFATE, MIRTAZAPINE, MIRTAZAPINE, MORPHINE, MORPHINE, MORPHINE SULFATE, MORPHINE SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREGABALIN, PREGABALIN, PREGABALIN, RANITIDINE, RANITIDINE, RANITIDINE, |
||||
| 718 | 25704618 |
US |
||
Toxicity to various agents, Overdose, Sinus bradycardia, Hypertension, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, FENTANYL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, QUININE, |
||||
| 719 | 25704662 |
CA |
||
Accident, Asthenia, Condition aggravated, Drug level decreased, Gait inability, Heart rate increased, Malaise, Mental disorder, Oxygen saturation decreased, Respiratory distress, Respiratory rate increased, Spinal disorder, Blood pressure increased, Apathy, Back pain, Depression, Hyperhidrosis, Intentional underdose, Inappropriate schedule of product administration, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 720 | 25704767 |
US |
1 | |
Incorrect dose administered, Product dose omission issue, Overdose, Drug ineffective, Device use issue, Device issue, Medication error, Drug ineffective, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE AND BUDESONIDE, |
||||
| 721 | 25705209 |
CH |
69 | 1 |
Lactic acidosis, Shock, Acute kidney injury, Toxicity to various agents, Overdose, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 722 | 25705282 |
US |
61 | 1 |
Overdose, |
||||
TIRZEPATIDE, |
||||
| 723 | 25705465 |
US |
2 | |
Dyspnoea, Dysphonia, Overdose, Product dose omission issue, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 724 | 25705560 |
US |
1 | |
Drug ineffective, Overdose, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL, |
||||
| 725 | 25705585 |
US |
21 | 1 |
Distributive shock, Respiratory failure, Lactic acidosis, Serotonin syndrome, Suicide attempt, Overdose, |
||||
AMLODIPINE BESYLATE, LISINOPRIL, SERTRALINE HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, |
||||
| 726 | 25706326 |
EU |
||
Pulmonary arterial hypertension, Hot flush, Diarrhoea, Headache, Overdose, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, IMATINIB, MACITENTAN, |
||||
| 727 | 25706435 |
CA |
36 | 2 |
Asthma, Back pain, Bursitis, Coeliac disease, Constipation, Drug hypersensitivity, Drug ineffective, Drug intolerance, Erythema, Fatigue, Fluid retention, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Immunodeficiency, Infection, Infusion related reaction, Intentional product misuse, Joint swelling, Off label use, Overdose, Pain, Prescribed overdose, Product use issue, Psoriasis, Pyrexia, Rash, Rash erythematous, Rheumatoid arthritis, Temperature regulation disorder, Thrombocytopenia, Upper respiratory tract infection, |
||||
ABATACEPT, ABACAVIR SULFATE, TOCILIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, BUPROPION, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, PROGESTERONE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DOLUTEGRAVIR SODIUM, ETANERCEPT, FLUCONAZOLE, FUROSEMIDE, GABAPENTIN, ASCORBIC ACID, ADALIMUMAB, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, PREGABALIN, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MOXIFLOXACIN HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, SENNA, SENNA LEAF, SENNOSIDES, STANDARDIZED SENNA CONCENTRATE, MONTELUKAST SODIUM, TEMAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ALBUTEROL SULFATE, BUPROPION HYDROCHLORIDE, TOFACITINIB, |
||||
| 728 | 25707487 |
US |
80 | 1 |
Overdose, |
||||
ENZALUTAMIDE, ENZALUTAMIDE, |
||||
| 729 | 25707680 |
US |
40 | 2 |
Liver injury, Overdose, Psoriasis, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 730 | 25707753 |
US |
30 | 1 |
Diarrhoea, Vomiting, Overdose, Inappropriate schedule of product administration, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 731 | 25707755 |
US |
2 | |
Overdose, Nausea, Salivary hypersecretion, Sluggishness, Dizziness, Feeling abnormal, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 732 | 25707843 |
US |
12 | 1 |
Ear infection, Positive airway pressure therapy, Product prescribing error, Overdose, |
||||
SAPROPTERIN DIHYDROCHLORIDE, SAPROPTERIN DIHYDROCHLORIDE, SAPROPTERIN DIHYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, |
||||
| 733 | 25707875 |
CA |
2 | |
Ankylosing spondylitis, Acne, Eczema, Drug ineffective, Overdose, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, DULOXETINE HYDROCHLORIDE, DULOXETINE, MONTELUKAST, ROSUVASTATIN, |
||||
| 734 | 25710623 |
44 | 2 | |
Overdose, |
||||
| 735 | 25697809 |
CA |
||
Anal fissure, Condition aggravated, Fistula, Inner ear disorder, Mental disorder, Post procedural complication, Pulmonary thrombosis, Arthralgia, Dizziness, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, BUDESONIDE, MESALAMINE, |
||||
| 736 | 25697844 |
CA |
||
Neoplasm malignant, Intestinal operation, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, PANTOPRAZOLE, PREDNISONE, |
||||
| 737 | 25697917 |
CA |
||
Hepatic failure, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, MESALAMINE, PREDNISONE, RABEPRAZOLE, |
||||
| 738 | 25698011 |
CA |
||
Abdominal distension, Anal fissure, Anxiety, Aphthous ulcer, Blood pressure diastolic increased, Condition aggravated, Defaecation urgency, Drug level decreased, Electrolyte depletion, Faeces hard, Fibromyalgia, Fistula, Flatulence, Gastrointestinal obstruction, Gingival pain, Heart rate increased, Intestinal obstruction, Lymphoid tissue hyperplasia, Malaise, Mouth ulceration, Nasal disorder, Nasal septum disorder, Nephrolithiasis, Neuralgia, Obstruction, Pharyngeal cyst, Post procedural complication, Rhinalgia, Sleep apnoea syndrome, Serum ferritin increased, Toothache, Troponin increased, Weight decreased, Weight increased, Anaemia, Arthralgia, Chest pain, Chills, Dizziness, Dyspnoea, Pain, Pyrexia, Tooth abscess, Uveitis, Off label use, Intentional product use issue, Inappropriate schedule of product administration, Therapy non-responder, Overdose, Underdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DIMENHYDRINATE, MAGNESIUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 739 | 25698029 |
CA |
||
Cough, Fall, Eye injury, Face injury, Nasal congestion, Nephrolithiasis, COVID-19, Conjunctivitis, Eczema, Syncope, Off label use, Intentional product use issue, Overdose, Underdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, |
||||
| 740 | 25698084 |
CA |
||
Aphthous ulcer, Arthralgia, Uveitis, Condition aggravated, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 741 | 25698136 |
CA |
||
Colitis, Condition aggravated, Drug level above therapeutic, Drug level decreased, Weight decreased, Weight increased, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, METHYLPREDNISOLONE, PANTOPRAZOLE, PREDNISONE, |
||||
| 742 | 25698239 |
CA |
||
Blood creatinine increased, Blood glucose increased, Blood pressure systolic increased, Condition aggravated, Glomerular filtration rate decreased, Haemoglobin decreased, Weight increased, Renal impairment, Arthralgia, COVID-19, Hypertension, Inappropriate schedule of product administration, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AMLODIPINE, DIMENHYDRINATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METHOTREXATE, METHOTREXATE SODIUM, HYDROCORTISONE SODIUM SUCCINATE, |
||||
| 743 | 25698261 |
CA |
||
Abdominal hernia, Gastrointestinal stoma complication, Hepatic cirrhosis, Small intestinal obstruction, Strangulated hernia, Heart rate increased, Pain, Cellulitis, Drug ineffective, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 744 | 25698300 |
CA |
||
Anal fissure, Anal fistula, Fistula discharge, Anal abscess, Condition aggravated, Inappropriate schedule of product administration, Off label use, Therapeutic response shortened, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 745 | 25698380 |
CA |
||
Weight increased, Condition aggravated, Decreased appetite, Eye inflammation, Hypophagia, Joint swelling, Micturition urgency, Mouth ulceration, Mucous stools, Blood pressure systolic increased, Uveitis, Weight decreased, Night sweats, Vomiting, Middle insomnia, Chills, Fatigue, Nausea, Arthralgia, Off label use, Therapeutic response shortened, Inappropriate schedule of product administration, Incorrect dose administered, Intentional product use issue, Product dose omission issue, Overdose, Underdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, |
||||
| 746 | 25698411 |
CA |
||
Condition aggravated, Inflammation, Pharyngeal disorder, Speech disorder, Illness, Pruritus, Rash, Inappropriate schedule of product administration, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ESCITALOPRAM OXALATE, ESCITALOPRAM, MESALAMINE, MESALAMINE, |
||||
| 747 | 25698501 |
CA |
||
Condition aggravated, Stress, Ear infection, Erythema, Neoplasm, Sinusitis, Tonsillitis, Urinary tract infection bacterial, Intentional product use issue, Off label use, Therapeutic response shortened, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 748 | 25698507 |
CA |
||
Body temperature abnormal, Breast mass, Condition aggravated, Ear pain, Nasal congestion, Otorrhoea, Tympanic membrane perforation, Cough, Alopecia, Arthralgia, Ear infection, Inappropriate schedule of product administration, Intentional product use issue, Off label use, Therapeutic response shortened, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 749 | 25698616 |
EU |
75 | 2 |
Electrocardiogram QT prolonged, Overdose, Accidental overdose, |
||||
LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
| 750 | 25698831 |
CA |
||
Arthralgia, Abscess, Herpes zoster, Gastrointestinal infection, Weight increased, Pain, Small intestinal resection, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, PREDNISONE, HYDROCORTISONE SODIUM SUCCINATE, |
||||
| 751 | 25698862 |
CA |
||
Condition aggravated, Cough, Middle insomnia, Anxiety, Bacterial infection, Infection, Pneumonia, Respiratory syncytial virus infection, Respiratory tract infection viral, Off label use, Overdose, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, CALCIUM, CANDESARTAN, INSULIN LISPRO, MAGNESIUM, MESALAMINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, PREDNISONE, ROSUVASTATIN, LEVOTHYROXINE SODIUM, INSULIN GLARGINE, |
||||
| 752 | 25698883 |
CA |
||
Blood pressure increased, Malaise, Joint swelling, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, |
||||
| 753 | 25698945 |
CA |
||
Crohn^s disease, Drug level below therapeutic, Feeling cold, Feeling hot, Ileostomy, Pyoderma gangrenosum, Small intestinal obstruction, Throat tightness, Wound, Drug specific antibody present, Dyspnoea, Hyperhidrosis, Infected skin ulcer, Nausea, Pelvic abscess, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, |
||||
| 754 | 25698953 |
CA |
||
Blood pressure increased, Blood pressure systolic increased, C-reactive protein increased, Carpal tunnel syndrome, Condition aggravated, Fall, Feeling cold, Sensitivity to weather change, Stress, White coat hypertension, Headache, Hypoaesthesia, Dizziness, Nasopharyngitis, Pain, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 755 | 25698987 |
CA |
||
Condition aggravated, Malaise, Pain, Ear infection, Myalgia, Nausea, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, |
||||
| 756 | 25699119 |
CA |
||
Condition aggravated, Rhinoplasty, Heart rate increased, Off label use, Drug ineffective, Inappropriate schedule of product administration, Incorrect product administration duration, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, |
||||
| 757 | 25699137 |
CA |
||
Pouchitis, Condition aggravated, Drug level decreased, Arthralgia, Nasopharyngitis, Inappropriate schedule of product administration, Off label use, Underdose, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DULOXETINE HYDROCHLORIDE, MIRTAZAPINE, |
||||
| 758 | 25699172 |
CA |
||
Condition aggravated, Weight decreased, Brain operation, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 759 | 25699205 |
CA |
||
Cataract, Off label use, Overdose, |
||||
INFLIXIMAB, |
||||
| 760 | 25699274 |
CA |
||
Aphthous ulcer, Condition aggravated, Pyoderma gangrenosum, Erythema nodosum, Arthralgia, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 761 | 25699288 |
CA |
||
Hepatic cancer, Weight decreased, Therapeutic response shortened, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, CANDESARTAN, METRONIDAZOLE, MESALAMINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ROSUVASTATIN, ROSUVASTATIN CALCIUM, |
||||
| 762 | 25699289 |
CA |
||
Poor quality sleep, Ligament sprain, Tendonitis, Asthenia, Migraine, Vitamin D decreased, Impaired work ability, Oral herpes, Fatigue, Constipation, Initial insomnia, Intentional product use issue, Inappropriate schedule of product administration, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE (XL), CEFIXIME, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, GABAPENTIN, MORPHINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ESTRADIOL, |
||||
| 763 | 25699320 |
CA |
||
Condition aggravated, Arthralgia, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 764 | 25699348 |
CA |
||
Condition aggravated, Dehydration, Mouth ulceration, Nasopharyngitis, Arthralgia, Off label use, Underdose, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ESCITALOPRAM OXALATE, ESCITALOPRAM, IRON, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 765 | 25699355 |
CA |
||
Anal fistula, Blood pressure systolic increased, C-reactive protein increased, Condition aggravated, Decreased appetite, Fistula, Infusion site extravasation, Infusion site mass, Swelling of eyelid, Abscess, Hypertension, Drug ineffective, Intentional product use issue, Off label use, Therapeutic response shortened, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, APIXABAN, DAPAGLIFLOZIN, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, METOPROLOL TARTRATE, METOPROLOL, MIRTAZAPINE, PREDNISONE, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
| 766 | 25699400 |
IN |
20 | 2 |
Overdose, Dizziness, Hypotension, Oliguria, Major depression, Intentional self-injury, |
||||
AMLODIPINE, |
||||
| 767 | 25699435 |
IN |
30 | 1 |
Overdose, Hyperhidrosis, Dizziness, Chest pain, Peripheral coldness, Hypotension, |
||||
AMLODIPINE, |
||||
| 768 | 25699440 |
IN |
50 | 2 |
Overdose, Cardiac arrest, Oliguria, Metabolic acidosis, Hyperhidrosis, Dizziness, Paraesthesia, Hypoaesthesia, Confusional state, Hypotension, |
||||
AMLODIPINE, |
||||
| 769 | 25699467 |
US |
2 | |
Headache, Overdose, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 770 | 25699525 |
EU |
22 | 1 |
Toxicity to various agents, Overdose, Poisoning deliberate, Drug interaction, Completed suicide, Intentional self-injury, |
||||
PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, QUETIAPINE FUMARATE, QUETIAPINE, ALPRAZOLAM, CLOZAPINE, |
||||
| 771 | 25699557 |
CA |
||
Haemorrhoids, Condition aggravated, Clostridium difficile infection, Molluscum contagiosum, Pyrexia, Therapeutic response shortened, Off label use, Intentional product use issue, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 772 | 25699615 |
VN |
||
Overdose, Toxicity to various agents, Metabolic acidosis, Pulmonary oedema, Cardiogenic shock, Sinus bradycardia, Acute kidney injury, |
||||
AMLODIPINE, ATENOLOL, |
||||
| 773 | 25699636 |
CA |
||
Condition aggravated, Chronic obstructive pulmonary disease, Arthralgia, Bronchitis, Weight control, Off label use, Underdose, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, BISOPROLOL FUMARATE, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, IRBESARTAN, OXYCODONE, LEVOTHYROXINE SODIUM, ALBUTEROL SULFATE, |
||||
| 774 | 25699742 |
CA |
||
Condition aggravated, Clostridium difficile infection, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, |
||||
| 775 | 25699788 |
US |
40 | 1 |
Cardiogenic shock, Overdose, Bradycardia, |
||||
FLUOXETINE HYDROCHLORIDE, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 776 | 25699965 |
IN |
86 | 2 |
Dysphagia, Oral disorder, Pancytopenia, Pyrexia, Toxicity to various agents, Overdose, Product prescribing error, |
||||
METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, |
||||
| 777 | 25699966 |
IN |
59 | 2 |
Mucocutaneous ulceration, Asthenia, Febrile neutropenia, Pancytopenia, Diarrhoea, Toxicity to various agents, Intentional product misuse, Overdose, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 778 | 25699996 |
CA |
||
Condition aggravated, Overdose, Underdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, FOLIC ACID, IRON, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, |
||||
| 779 | 25700143 |
CA |
||
Anal fissure, Asthenia, Blood pressure increased, Blood pressure systolic increased, Condition aggravated, Discharge, Eye pain, Flank pain, Malaise, Nasal ulcer, Rectal haemorrhage, Scab, Vision blurred, Weight decreased, Weight increased, Arthralgia, COVID-19, Headache, Nausea, Intentional product use issue, Off label use, Therapeutic response shortened, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, |
||||
| 780 | 25700181 |
CA |
||
Condition aggravated, Speech disorder, Vascular stent insertion, Illness, Overdose, Underdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, BISOPROLOL FUMARATE, AFLIBERCEPT, PREDNISONE, METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
| 781 | 25700411 |
CA |
||
Condition aggravated, Tuberculosis, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 782 | 25700414 |
CA |
||
Fistula, Cough, Dyspnoea, Nausea, Pruritus, Intentional product use issue, Off label use, Overdose, Underdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AMOXICILLIN, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 783 | 25700424 |
CA |
||
Anal fissure, Condition aggravated, Fistula, Intestinal obstruction, Abscess, Arthralgia, Psoriasis, Drug ineffective, Intentional product use issue, Off label use, Overdose, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 784 | 25700425 |
CA |
||
Condition aggravated, Prostate cancer, Prostatic specific antigen increased, Skin lesion, Body temperature decreased, Faecal calprotectin increased, Heart rate decreased, Drug specific antibody present, COVID-19, Myalgia, Drug level below therapeutic, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 785 | 25700426 |
CA |
||
Anal fissure, Aphthous ulcer, Condition aggravated, Fistula, Uveitis, Weight increased, Chest discomfort, Dyspepsia, Arthralgia, Abscess, Fatigue, Headache, Inappropriate schedule of product administration, Overdose, Underdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 786 | 25700582 |
US |
21 | 1 |
Distributive shock, Respiratory failure, Lactic acidosis, Serotonin syndrome, Suicide attempt, Overdose, |
||||
LISINOPRIL, TAMSULOSIN HYDROCHLORIDE, AMLODIPINE, SERTRALINE, |
||||
| 787 | 25700599 |
IL |
1 | |
Psychotic disorder, Overdose, |
||||
| 788 | 25700613 |
CA |
||
Nephrolithiasis, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 789 | 25701049 |
GB |
||
Thrombocytopenia, Leukocytosis, Mucosal inflammation, Leukopenia, Neutropenia, Rhinalgia, Neuropathy peripheral, Nausea, Dyspepsia, Diarrhoea, Cellulitis, Alopecia, Platelet count decreased, Fatigue, Delusion of grandeur, Incorrect dose administered, Lymphocyte count abnormal, SARS-CoV-2 test positive, Neutrophil count decreased, Hallucination, auditory, Extrapyramidal disorder, Affective disorder, Psychotic disorder, Schizophrenia, Disease progression, Neutrophil count increased, Seizure, Overdose, COVID-19, Neoplasm progression, Intentional product misuse, Lymphocyte count decreased, Off label use, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, PACLITAXEL, PACLITAXEL, PACLITAXEL, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, CHLORPROMAZINE, CHLORPROMAZINE, CHLORPROMAZINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, LORAZEPAM, LORAZEPAM, LORAZEPAM, PERTUZUMAB, PERTUZUMAB, PERTUZUMAB, PERTUZUMAB, PERTUZUMAB, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, DENOSUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CHLORPHENIRAMINE MALEATE, DENOSUMAB, DENOSUMAB, RANITIDINE, RANITIDINE, RANITIDINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, GENTAMICIN, GENTAMICIN SULFATE, MIRTAZAPINE, MIRTAZAPINE, MORPHINE, MORPHINE, MORPHINE SULFATE, MORPHINE SULFATE, PREGABALIN, PREGABALIN, PREGABALIN, |
||||
| 790 | 25701103 |
GB |
||
Anxiety, Overdose, Suicidal ideation, Depression, Myalgia, Aggression, Anaemia, Decreased appetite, Oral discomfort, Malaise, Vomiting, Illness anxiety disorder, Muscle twitching, Muscle atrophy, Pain, Panic attack, Tremor, Hyperhidrosis, Urinary tract infection, Syncope, Insomnia, Lethargy, Nausea, Confusional state, Weight decreased, Dizziness, Diarrhoea, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), ATENOLOL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, SERTRALINE, SERTRALINE, SIMVASTATIN, SIMVASTATIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PROMETHAZINE, PROMETHAZINE, |
||||
| 791 | 25701120 |
US |
2 | 2 |
Sleep disorder, Psychomotor hyperactivity, Overdose, Product prescribing error, |
||||
SAPROPTERIN DIHYDROCHLORIDE, SAPROPTERIN DIHYDROCHLORIDE, |
||||
| 792 | 25701154 |
US |
40 | 1 |
Cardiogenic shock, Toxicity to various agents, Overdose, |
||||
METOPROLOL TARTRATE, METOPROLOL, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 793 | 25701155 |
US |
40 | 1 |
Cardiogenic shock, Toxicity to various agents, Overdose, |
||||
METOPROLOL TARTRATE, METOPROLOL, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 794 | 25701234 |
EU |
||
Overdose, Anticoagulation drug level increased, Rectal haemorrhage, |
||||
RIVAROXABAN, |
||||
| 795 | 25701889 |
US |
68 | 2 |
Overdose, |
||||
MINOXIDIL, MINOXIDIL, |
||||
| 796 | 25702011 |
CA |
36 | 2 |
Asthma, Back pain, Bursitis, Coeliac disease, Constipation, Contraindicated product administered, Drug hypersensitivity, Drug ineffective, Drug intolerance, Erythema, Maternal exposure during pregnancy, Fatigue, Fluid retention, Foetal death, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Immunodeficiency, Infection, Infusion related reaction, Intentional product misuse, Joint swelling, Off label use, Overdose, Pain, Prescribed overdose, Product use issue, Psoriasis, Pyrexia, Rash, Rash erythematous, Rheumatoid arthritis, Temperature regulation disorder, Thrombocytopenia, Treatment failure, Upper respiratory tract infection, |
||||
RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, PREGABALIN, |
||||
| 797 | 25688221 |
IR |
26 | 2 |
Overdose, Toxicity to various agents, |
||||
MORPHINE, AMPHETAMINE, |
||||
| 798 | 25688383 |
US |
51 | 1 |
Serotonin syndrome, Overdose, Product use in unapproved indication, |
||||
BUPROPION HYDROCHLORIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 799 | 25688788 |
US |
50 | 1 |
Death, Cardiac arrest, Electrocardiogram QRS complex prolonged, Electrocardiogram QT prolonged, Overdose, Mental status changes, Electrocardiogram abnormal, Toxicity to various agents, Seizure, Diarrhoea, Abdominal pain, |
||||
ARIPIPRAZOLE, DILTIAZEM HYDROCHLORIDE, |
||||
| 800 | 25689189 |
US |
||
Sinus bradycardia, Heart rate decreased, Hypotension, Drug abuse, Overdose, |
||||
DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FENTANYL, HYDROXYZINE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, MIRTAZAPINE, NALOXONE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, SERTRALINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30